Presentation is loading. Please wait.

Presentation is loading. Please wait.

DENİZ KAVGACI HALİME HELİN YILMAZ

Similar presentations


Presentation on theme: "DENİZ KAVGACI HALİME HELİN YILMAZ"— Presentation transcript:

1 DENİZ KAVGACI HALİME HELİN YILMAZ
TESTICULAR TUMORS DENİZ KAVGACI HALİME HELİN YILMAZ

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32 TNM STAGING American Joint Committee on Cancer (AJCC) T the extent of spread of the primary tumor to the tissues next to the testicle N number of lymph nodes affected M metastasis +/- S indicates the serum level of tumor markers (specific for certain types of testicular cancers)

33 STAGING OF TESTICULAR CANCER
Stage I: tumor confined to the testis Stage II: spread to regional lymph nodes IIA: <2 cm in size or < 6 positive nodes IIB: 2-5 cm in size or > 6 positive nodes IIC: large and bulky abdominal mass, usually > 5-10 cm Stage III: spread beyond retroperitoneal nodes or above diaphragm or visceral disease Stage IV: hematogenous spread

34

35

36

37

38 TREATMENT OF SEMINOMAS
 Low grade (stage I and IIA) Radical inguinal orchiectomy Surveillance RT or single agent carboplatin  High grade (stage >IIA) RPLND RT and/or CT

39 NON-SEMINOMATOUS GERM CELL TUMOR
Management of men with NSGCT stage I depends on the presence of factors that present an increased risk of relapse: - Lymphovascular invasion - Predominance of an embryonal carcinoma component - A T3 or T4 primary tumor

40 NSGCT TREATMENT

41

42

43

44

45 REFERANCES THANK YOU…


Download ppt "DENİZ KAVGACI HALİME HELİN YILMAZ"

Similar presentations


Ads by Google